The Present Clinical Treatment and Future Emerging Interdisciplinary for Heart Failure: Where we are and What we can do

被引:0
作者
Yu Yang
Jiamin Gao
Zhen Qin
Yongzheng Lu
Yanyan Xu
Jiacheng Guo
Xiaolin Cui
Jinying Zhang
Junnan Tang
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Cardiology
[2] Henan Province Key Laboratory of Cardiac Injury and Repair,School of Medicine
[3] Henan Province Clinical Research Center for Cardiovascular Diseases,undefined
[4] The Chinese University of Hong Kong,undefined
来源
Intensive Care Research | 2023年 / 3卷 / 1期
关键词
Heart failure; Clinical Treatment; Interdisciplinary; Future Perspective;
D O I
10.1007/s44231-023-00029-4
中图分类号
学科分类号
摘要
Heart failure is a complex clinical syndrome caused by the progression to severe stages of various cardiac diseases, characterized by high morbidity and mortality. With the increasing aging of the population and the poor control of high-risk factors for heart failure such as hypertension and diabetes, the incidence of heart failure remains high. Therefore, there is widespread global attention regarding the various treatments for heart failure. Currently, pharmacological therapy, associated device therapy, interventional therapy, and end-stage surgical related therapy are the main clinical treatments for heart failure. Heart failure treatment is gradually evolving to be more precise, safe, and effective, as traditional therapies can no longer match clinical needs. A number of cutting-edge research studies are being conducted on the treatment of heart failure, based on the different pathogenesis and causes of heart failure, to treat patients with heart failure in a multifaceted and integrated way. This article summarizes the current clinical treatment of heart failure and the latest therapeutic advances in heart failure in current research to further promote the standardized management and treatment of heart failure and improve patient prognosis.
引用
收藏
页码:3 / 11
页数:8
相关论文
共 92 条
  • [1] Mele D(2018)Left ventricular ejection fraction and heart failure: an indissoluble marriage? Eur J Heart Fail 20 427-430
  • [2] Nardozza M(2022)AHA/ACC/HFSA Guideline for the management of heart failure: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines Circulation 145 e895-e1032
  • [3] Ferrari R(2022)An update on global epidemiology in heart failure Eur Heart J 43 3005-3007
  • [4] Heidenreich PA(2021)The heart failure association atlas: heart failure epidemiology and management statistics 2019 Eur J Heart Fail 23 906-914
  • [5] Becher PM(2014)The annual global economic burden of heart failure Int J Cardiol 171 368-376
  • [6] Seferovic PM(2022)Global burden of heart failure: A comprehensive and updated review of epidemiology Cardiovasc Res 118 3272-2142
  • [7] Cook C(2022)Heart failure risk associated with severity of modifiable heart failure risk factors: the aric study J Am Heart Assoc 11 e021583-1663
  • [8] Savarese G(2021)Health-related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries Circulation 143 2129-e672
  • [9] Hamo CE(2021)Sex differences in heart failure hospitalisation risk following acute myocardial infarction Heart 107 1657-1995
  • [10] Johansson I(2017)Global mortality variations in patients with heart failure: results from the international congestive heart failure (INTER-CHF) prospective cohort study Lancet Glob Health 5 e665-20